FI850023L - Foerfarande foer framstaellning av en ny antibiotisk foerening. - Google Patents

Foerfarande foer framstaellning av en ny antibiotisk foerening.

Info

Publication number
FI850023L
FI850023L FI850023A FI850023A FI850023L FI 850023 L FI850023 L FI 850023L FI 850023 A FI850023 A FI 850023A FI 850023 A FI850023 A FI 850023A FI 850023 L FI850023 L FI 850023L
Authority
FI
Finland
Prior art keywords
antibiotisk
foerening
foerfarande foer
foer framstaellning
framstaellning
Prior art date
Application number
FI850023A
Other languages
English (en)
Other versions
FI77249B (fi
FI850023A0 (fi
FI77249C (fi
Inventor
Martti Lauri Antero Marvola
Esko Veikko Marttila
Jaakko Antero Uotila
Aino Kyllikki Pippuri
Pekka Juhani Kairisalo
Erkki Juhani Honkanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of FI850023A0 publication Critical patent/FI850023A0/fi
Publication of FI850023L publication Critical patent/FI850023L/fi
Publication of FI77249B publication Critical patent/FI77249B/fi
Application granted granted Critical
Publication of FI77249C publication Critical patent/FI77249C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
FI850023A 1984-01-06 1985-01-03 Foerfarande foer framstaellning av en ny antibiotisk foerening. FI77249C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK5884 1984-01-06
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (4)

Publication Number Publication Date
FI850023A0 FI850023A0 (fi) 1985-01-03
FI850023L true FI850023L (fi) 1985-07-07
FI77249B FI77249B (fi) 1988-10-31
FI77249C FI77249C (fi) 1989-02-10

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850023A FI77249C (fi) 1984-01-06 1985-01-03 Foerfarande foer framstaellning av en ny antibiotisk foerening.

Country Status (38)

Country Link
US (1) US4599326A (fi)
JP (1) JPS60158197A (fi)
KR (1) KR900006237B1 (fi)
AT (1) AT386414B (fi)
AU (1) AU565688B2 (fi)
BE (1) BE901411A (fi)
BG (1) BG43189A3 (fi)
CA (1) CA1224461A (fi)
CH (1) CH666275A5 (fi)
CS (1) CS247191B2 (fi)
CY (1) CY1462A (fi)
DE (1) DE3500179A1 (fi)
DK (1) DK149776C (fi)
ES (1) ES8605818A1 (fi)
FI (1) FI77249C (fi)
FR (1) FR2557878B1 (fi)
GB (1) GB2152502B (fi)
HK (1) HK11590A (fi)
HU (1) HU196221B (fi)
IE (1) IE57967B1 (fi)
IL (1) IL73885A (fi)
IS (1) IS2968A7 (fi)
IT (1) IT1184304B (fi)
KE (1) KE3841A (fi)
LU (1) LU85721A1 (fi)
MA (1) MA20316A1 (fi)
MX (1) MX156277A (fi)
NL (1) NL8403979A (fi)
NO (1) NO160263C (fi)
NZ (1) NZ210606A (fi)
PH (1) PH22471A (fi)
PL (1) PL144349B1 (fi)
PT (1) PT79777B (fi)
RO (1) RO91262B (fi)
SE (1) SE461854B (fi)
SU (1) SU1410866A3 (fi)
YU (1) YU44485B (fi)
ZA (1) ZA8410143B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル， インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP1680083A1 (en) * 2003-10-31 2006-07-19 ALZA Corporation Compositions and dosage forms for ehnanced absorption of iron
ES2653568T3 (es) 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Formulaciones de fármacos para la prevención del abuso
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
EP1789075A4 (en) 2004-08-25 2009-07-01 Uab Research Foundation ABSORPTION ENHANCER FOR DRUG ADMINISTRATION
CA2743725A1 (en) 2006-06-23 2007-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CN108892709A (zh) 2011-05-18 2018-11-27 欧莫德里斯制药公司 改良的肽药物
EP3444281B1 (en) 2012-11-20 2021-11-03 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
MX360816B (es) 2012-11-20 2018-11-15 Mederis Diabetes Llc Productos farmacéuticos peptídicos mejorados para la resistencia a la insulina.
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
MX371033B (es) 2014-05-28 2020-01-13 Mederis Diabetes Llc Productos farmacéuticos mejorados de péptido para resistencia a la insulina.
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
EP3624840A4 (en) * 2017-05-19 2021-03-10 Lunella Biotech, Inc. ANTIMITOSCINE: TARGETED INHIBITORS OF MITOCHONDRIAL BIOGENESIS TO DESCRIBE CANCER STEM CELLS
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
MX2020008132A (es) 2018-02-06 2020-11-18 Aegis Therapeutics Llc Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades.
JP2022516414A (ja) * 2018-12-17 2022-02-28 ルネラ・バイオテック・インコーポレーテッド ミトコンドリアを標的化し癌幹細胞を死滅させるための三剤併用療法
BR112021011964A2 (pt) * 2018-12-17 2021-09-08 Lunella Biotech, Inc. Terapias de combinação tripla para antienvelhecimento

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
AU565688B2 (en) 1987-09-24
BE901411A (fr) 1985-04-16
SE461854B (sv) 1990-04-02
CY1462A (en) 1989-07-21
DK5884D0 (da) 1984-01-06
FR2557878A1 (fr) 1985-07-12
SE8406671D0 (sv) 1984-12-28
FI77249B (fi) 1988-10-31
KR900006237B1 (ko) 1990-08-27
SE8406671L (sv) 1985-07-07
ES8605818A1 (es) 1986-04-01
CS247191B2 (en) 1986-12-18
CH666275A5 (de) 1988-07-15
MX156277A (es) 1988-08-04
ZA8410143B (en) 1985-08-28
RO91262B (ro) 1987-07-01
RO91262A (ro) 1987-06-30
NO160263B (no) 1988-12-19
DK149776C (da) 1987-04-21
NZ210606A (en) 1987-08-31
DK5884A (da) 1985-07-07
YU44485B (en) 1990-08-31
ES539349A0 (es) 1986-04-01
GB2152502B (en) 1987-10-07
LU85721A1 (fr) 1985-07-24
JPH029040B2 (fi) 1990-02-28
ATA985A (de) 1988-01-15
DK149776B (da) 1986-09-29
SU1410866A3 (ru) 1988-07-15
FI850023A0 (fi) 1985-01-03
IE57967B1 (en) 1993-06-02
GB2152502A (en) 1985-08-07
PT79777B (en) 1986-10-21
KE3841A (en) 1989-04-07
US4599326A (en) 1986-07-08
IE850022L (en) 1985-07-06
AU3705984A (en) 1985-07-11
PL251457A1 (en) 1985-11-05
IL73885A0 (en) 1985-03-31
PL144349B1 (en) 1988-05-31
PT79777A (en) 1985-01-01
GB8432368D0 (en) 1985-02-06
NO160263C (no) 1989-03-29
DE3500179A1 (de) 1985-07-18
YU2085A (en) 1987-12-31
NO850007L (no) 1985-07-08
FR2557878B1 (fr) 1988-01-15
HU196221B (en) 1988-10-28
PH22471A (en) 1988-09-12
IS2968A7 (is) 1985-04-03
IT1184304B (it) 1987-10-28
JPS60158197A (ja) 1985-08-19
FI77249C (fi) 1989-02-10
IT8519012A0 (it) 1985-01-04
IL73885A (en) 1988-10-31
HK11590A (en) 1990-02-23
KR850005452A (ko) 1985-08-26
CA1224461A (en) 1987-07-21
MA20316A1 (fr) 1985-10-01
DE3500179C2 (fi) 1989-08-24
HUT37628A (en) 1986-01-23
BG43189A3 (en) 1988-04-15
AT386414B (de) 1988-08-25
NL8403979A (nl) 1985-08-01

Similar Documents

Publication Publication Date Title
FI844046A0 (fi) Foerfarande foer framstaellning av polytriaziner fraon aromatiska polycyanater.
FI83882B (fi) Foerfarande foer framstaellning av blodlevring haemmande proteiner.
FI853030A0 (fi) Foerfarande foer framstaellning av skarpgraensad spektroskopisk nmr-bild fraon kemiskt foerflyttande kaernor.
FI850023A0 (fi) Foerfarande foer framstaellning av en ny antibiotisk foerening.
FI860904A (fi) Ny amidinfoerening.
FI852216L (fi) Foerfarande foer framstaellning av terapeutiskt aktiva triterpenylestrar av organiska syror.
FI840174A (fi) Foerfarande foer optisk maetning av laongstraeckta stycken.
FI80896B (fi) Foerfarande foer framstaellning av fenolskum.
FI852731L (fi) Foerfarande foer framstaellning av alfa-l-aspartyl-l-fenylalaninalkylestrar.
FI850768L (fi) Foerfarande foer eftergarvning av mineralgarvat laeder.
FI840758A (fi) Anlaeggning foer utnyttjande av vaermeenergi alstrad av en bastuugn.
FI841768A0 (fi) Anordning foer rullning av traedstammar.
FI841518A0 (fi) Foerfarande foer framstaellning av stabila injektionspreparat av indolylalifatiska syraderivat.
FI841368A0 (fi) Anordning foer jaemning av sandskikt.
FI80875B (fi) Framstaellning av isobutyrylfluorid.
FI843717L (fi) Elektrod foer elektrolys av elektrolytloesningar.
FI841565A0 (fi) Foerfarande foer reglering av stickkraft av bildaecksdubbar.
FI851173L (fi) Foerfarande foer framstaellning av cefalosporin.
FI841139A (fi) Anordning foer inledning av ledningar.
FI841371A (fi) Foerfarande foer framstaellning av integrerade kretsar av mos-typ.
FI841366A (fi) Foerfarande foer kokning av foerhydrolyssulfatcellulosa.
FI844887L (fi) Foerfarande foer regenerering av asfaltbetong.
FI840038A (fi) Foerfarande foer avledande av foerbraenningsgaser.
FI841478A (fi) Foerfarande foer framstaellning av en kulformad kopplingsdel foer vaetskeavspaerrningsorgan.
FI841365A0 (fi) Cellenhet foer skolning av plantor.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: ORION-YHTYMAE OY

MA Patent expired